Brief: Active Biotech Reports Intriguing Intraocular Levels in Laquinimod Eye Drops Study

Active Biotech AB publ

10/09/2024 07:47

Sept 10 (Reuters) - Active Biotech AB publ  ACTI.ST :
    * ACTIVE BIOTECH REPORTS INTRIGUING INTRAOCULAR
CONCENTRATIONS
ACHIEVED IN A CLINICAL BIODISTRIBUTION STUDY OF LAQUINIMOD EYE
DROPS
    * ACTIVE BIOTECH AB PUBL - TOP-LINE RESULTS EXPECTED IN LATE
2024/EARLY 2025

Source text for Eikon:  ID:nMFN59gr24 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))